Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

NCT02549638 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02549638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02549638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Terminated
Start date
April 8, 2015
Completion date
April 23, 2020
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of lung, cancer of the lung, carcinoma, squamous, carcinoma, squamous cell, lung cancer, lung neoplasms, neoplasms, lung, neoplasms, pulmonary, pulmonary cancer, pulmonary neoplasms, squamous cell carcinoma